Globalink Investment INC
Market Movers (8-K)
Globalink Investment Inc. stockholders overwhelmingly approved the business combination with Alps Life Sciences Inc. and related charter amendments, paving the way for the merger.
Delay expected
Globalink Investment Inc. has extended its deadline to complete a business combination to November 9, 2025, by depositing $10,890.15 into its trust account.
Worse than expected
Delay expected
Globalink Investment Inc. and Alps Life Sciences Inc. have amended their merger agreement, adjusting escrow terms and extending the shareholder consent deadline.
Delay expected
Globalink Investment Inc. has extended its deadline to complete an initial business combination to October 9, 2025, marking its twenty-seventh extension.
Worse than expected
Delay expected
Globalink Investment Inc. announced it will restate its 2024 annual and Q1 2025 financial statements due to accounting errors related to redemption overpayments and per-share price calculations.
Worse than expected
Delay expected
Globalink Investment Inc. extends its deadline to complete a business combination to September 9, 2025, marking its twenty-sixth extension.
Worse than expected
Delay expected
Quarterly Earnings (10-Q)
Globalink Investment Inc. reports a significant net loss and working capital deficit, with its Nasdaq listing terminated and a critical business combination facing ongoing challenges and redemptions.
Delay expected
Worse than expected
Capital raise
Globalink Investment Inc. filed an amended quarterly report, restating financials due to redemption calculation errors, while grappling with Nasdaq delisting and significant liquidity concerns.
Worse than expected
Delay expected
Capital raise
Globalink Investment Inc., a blank check company, reported a significant net loss and dwindling cash reserves for Q1 2025, raising substantial doubt about its ability to continue as a going concern, while its securities have been delisted from Nasdaq.
Worse than expected
Delay expected
Capital raise
10-Q: Globalink Investment Inc. Reports Third Quarter 2024 Results Amidst Business Combination Efforts
Globalink Investment Inc. reported a net loss for the third quarter of 2024, while continuing its efforts to complete a business combination.
Worse than expected
Delay expected
Capital raise
Globalink Investment Inc. reported a net loss for the second quarter of 2024 and has extended its deadline to complete a business combination to September 9, 2024, with a potential further extension to December 9, 2024.
Worse than expected
Delay expected
Capital raise
10-Q: Globalink Investment Inc. Reports First Quarter 2024 Results Amidst Business Combination Efforts
Globalink Investment Inc. reported a net loss for the first quarter of 2024, while continuing its efforts to secure a business combination.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
Globalink Investment Inc. filed an amended annual report for 2024, restating financials due to redemption calculation errors, while facing Nasdaq delisting and ongoing challenges to complete its merger with Alps Holdco.
Worse than expected
Delay expected
Capital raise
Globalink Investment Inc.'s annual report reveals substantial doubt about its ability to continue as a going concern due to Nasdaq delisting, failure to meet business combination deadline, and significant redemptions.
Worse than expected
Capital raise
Globalink Investment Inc.'s 10-K filing details financial results, a merger agreement with Alps Global Holding Berhad, and ongoing efforts to secure a business combination.
Worse than expected
Delay expected
Capital raise
Insider Trading (Form 4)
Globalink Investment Inc. and Alps Life Sciences Inc. amended their merger agreement, adjusting escrow share contributions and extending the shareholder consent deadline.
Delay expected
Proxy Statements (Def-14A)
Globalink Investment Inc. and Alps Life Sciences Inc. have amended their merger agreement, adjusting escrow share contributions and extending the Alps Holdco shareholder consent deadline.
Delay expected
Globalink Investment Inc. seeks stockholder approval for a two-step business combination with Alps Life Sciences Inc., valuing Alps Holdco at $1.6 billion, despite significant PIPE investment reduction and Nasdaq delisting.
Worse than expected
Delay expected
Capital raise
Globalink Investment Inc. is holding a special meeting to vote on proposals to extend the deadline for completing a business combination from June 9, 2025, to potentially December 9, 2025.
Worse than expected
Delay expected
DEFR14A: Globalink Investment Inc. Amends Proxy Statement for Special Meeting Regarding Extension Amendment
Globalink Investment Inc. has amended its proxy statement to provide supplemental information about the proposed extension to complete a business combination, clarifying conditions and potential impacts.
Delay expected
Globalink Investment Inc. is seeking stockholder approval to extend the deadline for completing a business combination from December 9, 2024, to potentially June 9, 2025, along with other related proposals.
Worse than expected
Delay expected
Schedule 13G - Passive Investments
SCHEDULE 13G/A: Atlas Merchant Capital Group Divests Entire Stake in Globalink Investment Inc., Beneficial Ownership Drops to Zero
Atlas Merchant Capital and its affiliated entities have reported a complete divestment of their beneficial ownership in Globalink Investment Inc., reducing their stake to 0% as of December 31, 2024.
Worse than expected
Karpus Management, Inc. has filed an amended Schedule 13G indicating it no longer holds beneficial ownership in Globalink Investment Inc. as of December 31, 2024.